Bittensor’s SN68 subnet accelerates drug R&D at Metanova Labs
Getting a new drug from lab bench to pharmacy shelf typically takes more than a decade and costs billions of dollars. And after all that time and money, more than 90% of drug candidates still fail. Metanova Labs thinks decentralized AI can change the math. The company operates NOVA, a specialized network running on Bittensor’s…
